Skip to main content
. Author manuscript; available in PMC: 2009 Apr 28.
Published in final edited form as: Brain Res. 2008 Jan 26;1200:138–145. doi: 10.1016/j.brainres.2008.01.045

Figure 2.

Figure 2

Caspase activities in brain homogenates increased following LPS administration with caspase-9 and caspase-10 activity maximal at 1 h after LPS (increase from baseline ± SEM; caspase-9: 1 h – 141 ± 35%, 2 h – 70 ± 20%, 4 h – 13 ± 11%; caspase-10: 1 h – 155 ± 40%, 2 h – 89 ± 21%, 4 h - −5 ± 10%; p < 0.05 for 1 h and 2 h for both caspase-9 and -10), caspase-8 activity maximal at 2 h (1 h – 40 ± 21%, 2 h – 46 ± 14%, 4 h – 10 ± 11%; p < 0.05 for 1 h and 2 h) and caspase-3 maximal at 4 h (1 h – 26 ± 15%, 2 h – 18 ± 11%, 4 h - 24 ± 9%; p < 0.05 only for 4 h).